No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 18 of the 40 quarters in the window, leaving 22 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T11:55:42.316Z. Latest historical point 2025-03-27. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T11:55:42.316Z. Latest historical point 2026-03-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T11:55:42.316Z. Latest historical point 2026-03-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for AquaBounty Technologies, Inc. (AQB) stock was $0.89 as of Oct 5, 2026, 4:00 PM EDT, down 4.20% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -61.0% · 3-year avg -44.4%/yr · 5-year avg -59.0%/yr
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada.
Agricultural Farm Products · Maynard, MA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2023-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 10, 2026
35 days away
EPS Estimate
-1.30
Revenue Est.
$265000.00
Last Quarter Results
EPS
$-0.88
vs Estimate
$-0.88
Revenue
$0.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AQB | $4.56M | $0.89 | -4.20% | -60.96% | -59.04% | N/A | N/A |
| 2FAMI | $4.53M | $0.12 | -4.20% | -93.69% | -82.70% | N/A | vs AQB |
| 3EEIQ | $4.14M | $5.07 | -0.29% | -32.36% | -40.97% | N/A | vs AQB |
| 4AGRZ | $3.69M | $3.40 | +4.77% | -93.76% | N/A | N/A | vs AQB |
| 5CHSN | $2.46M | $1.06 | -1.85% | -99.58% | N/A | N/A | vs AQB |
| 6ATPC | $2.12M | $2.12 | +2.85% | -96.30% | -80.48% | N/A | vs AQB |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.89
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-1.30 | $-1.30 | $-1.30 | 1 |
| Quarter ending Dec 2026 | $-1.30 | $-1.30 | $-1.30 | 1 |
| Quarter ending Mar 2027 | $-1.45 | $-1.45 | $-1.45 | 1 |
| Quarter ending Jun 2027 | $-1.60 | $-1.60 | $-1.60 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-7.28 | $-7.28 | $-7.28 | 1 |
| FY 2027 | $-7.12 | $-7.12 | $-7.12 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $265000.00 | $265000.00 | $265000.00 | 1 |
| Quarter ending Dec 2026 | $100000.00 | $100000.00 | $100000.00 | 1 |
| Quarter ending Mar 2027 | $697500.00 | $697500.00 | $697500.00 | 1 |
| Quarter ending Jun 2027 | $847500.00 | $847500.00 | $847500.00 | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $500000.00 | $500000.00 | $500000.00 | 1 |
| FY 2027 | $2.50M | $2.50M | $2.50M | 1 |
